In order to be able to develop novel individualized forms of therapy in the future, scientists in the project coordinated by Leibniz HKI are researching molecules and therapeutic microbes as well as certain proteins and antibodies, as an alternative to conventional antibiotics. Photonics-based molecular and biochemical assays are being developed for rapid diagnostics. The subproject of the Leibniz IPHT combines different methods for the detection of pathogens and represents the complete diagnostic process from the sample to the detected pathogen and the resulting result.

The project is funded by the BMBF and supervised by the VDI Technology Center under the number 13N15717.